 |
 |

Epoetin Dosing and Dialysis Facility Ownership—Reply
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
In Reply: Dr Regidor and colleagues suggest that their observational data1 are similar to clinical trial results. Figure 1 of their study1 shows the adjusted relative hazard ratio of death is approximately 1.5 when the hemoglobin level is 10.0 g/dL vs 1.0 when the hemoglobin level is 13.0 g/dL, while the largest dialysis anemia trial achieving those mean values found a 22% higher relative risk of death from a higher hemoglobin level.2 The study by Regidor et al1 also shows that the hazard ratio of death decreases from approximately 1.4 when the hemoglobin level is 10.0 g/dL to 11.0 g/dL to approximately 0.9 when the hemoglobin level is near 12.0 g/dL. However, actual adjusted mortality among US dialysis patients has not changed, although the mean hemoglobin level has steadily increased from 10 g/dL in 1993 to 12.0 g/dL in 2004.3
Regidor et al1 examined achieved hemoglobin values, yet the writers . . . [Full Text of this Article]
Daniel W. Coyne, MD
dcoyne@im.wustl.edu Department of Medicine Washington University School of Medicine St Louis, Missouri
CiteULike Connotea Del.icio.us Digg Reddit Technorati
What's this?
RELATED LETTERS
Epoetin Dosing and Dialysis Facility Ownership
Alan S. Kliger and Allen R. Nissenson
JAMA. 2007;298(8):861-862.
EXTRACT
| FULL TEXT
Epoetin Dosing and Dialysis Facility Ownership
Deborah L. Regidor, Kamyar Kalantar-Zadeh, and Csaba P. Kovesdy
JAMA. 2007;298(8):862.
EXTRACT
| FULL TEXT
Epoetin Dosing and Dialysis Facility Ownership—Reply
Mae Thamer, Yi Zhang, Dennis J. Cotter, James Kaufman, and Miguel A. Hernán
JAMA. 2007;298(8):862.
EXTRACT
| FULL TEXT
RELATED ARTICLE
Dialysis Facility Ownership and Epoetin Dosing in Patients Receiving Hemodialysis
Mae Thamer, Yi Zhang, James Kaufman, Dennis Cotter, Fan Dong, and Miguel A. Hernán
JAMA. 2007;297(15):1667-1674.
ABSTRACT
| FULL TEXT
|